Ophthalmic Diagnostic Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Ophthalmic Diagnostic Equipment Pipeline Market Report Overview

Ophthalmic diagnostic equipment helps in examining the eye for study purposes as well as for the treatment of different pathologies of the eye. The Ophthalmic Diagnostic Equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·        Optical Coherence Tomography (OCT)

·        Tonometers

·        Fundus Cameras

·        Ophthalmoscopes

·        Perimeters

·        Others

Key Territories ·        The US

·        Europe

·        China

·        Australia

·        India

Key Regulatory Paths ·        510(k)

·        CE

·        NMPA

·        TGA

·        ICAC

Leading Companies ·        AcuMEMS

·        Adom Advanced Optical Technologies Ltd

·        Aeon Imaging, LLC

·        Alcon Inc

·        Atlanta VA Medical Center

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Ophthalmic Diagnostic Equipment Pipeline Market by Segments

A few of the key segments in the ophthalmic diagnostic equipment pipeline market are optical coherence tomography (OCT), tonometers, fundus cameras, ophthalmoscopes, and perimeters, among others. As of December 2023, optical coherence tomography (OCT) accounted for the highest number of pipeline products.

Ophthalmic Diagnostic Equipment Pipeline Market Analysis by Segments, 2023 (%)

Ophthalmic Diagnostic Equipment Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Ophthalmic Diagnostic Equipment Pipeline Market

Download a Free Report Sample

Ophthalmic Diagnostic Equipment Pipeline Market Segmentation by Territories

A few of the key territories for ophthalmic diagnostic equipment pipeline products are the US, Europe, China, Australia, and India. As of December 2023, the US accounted for the highest number of pipeline products.

Ophthalmic Diagnostic Equipment Pipeline Market Analysis by Territories, 2023 (%)

Ophthalmic Diagnostic Equipment Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Ophthalmic Diagnostic Equipment Pipeline Market

Download a Free Report Sample

Ophthalmic Diagnostic Equipment Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the ophthalmic diagnostic equipment pipeline market are 510(k), CE, NMPA, TGA, and ICAC. As of December 2023, 510(k) was the most followed pathway for pipeline products in the market.

Ophthalmic Diagnostic Equipment Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Ophthalmic Diagnostic Equipment Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Ophthalmic Diagnostic Equipment Pipeline Market

Download a Free Report Sample

Ophthalmic Diagnostic Equipment Pipeline Market – Competitive Landscape

A few of the key companies associated with the ophthalmic diagnostic equipment pipeline market are AcuMEMS, Adom Advanced Optical Technologies Ltd, Aeon Imaging, LLC, Alcon Inc., and Atlanta VA Medical Center, among others.

Alcon Inc (Alcon): Alcon is headquartered in Geneva, Switzerland, and has operations in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It is engaged in the development and manufacturing of ophthalmology devices. Alcon’s pipeline products are developed through collaboration with institutions, medical innovators, research advisors, and academic thought leaders.

U.S. Atlanta VA Medical Center (VAMC): VAMC is headquartered in Decatur, Georgia, the US. It is a healthcare service provider that offers medical, surgical, and geriatric specialty services. VAMC partners with other institutions to provide educational and research services as well. The center operates through hospitals, community clinics, community living centers, domiciliaries, readjustment counseling centers, and various facilities, among others.

Ophthalmic Diagnostic Equipment Pipeline Market Analysis by Companies, 2023

Ophthalmic Diagnostic Equipment Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Ophthalmic Diagnostic Equipment Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Ophthalmic Diagnostic Equipment Pipeline Market Segments Outlook

  • Optical Coherence Tomography (OCT)
  • Tonometers
  • Fundus Cameras
  • Ophthalmoscopes
  • Perimeters
  • Retinal Ultrasound Imaging Systems
  • Slit Lamps
  • Auto Refractors & Keratometers
  • Indirect Ophthalmoscopes
  • Acuity Systems
  • Lensometers
  • Direct Ophthalmoscopes

Ophthalmic Diagnostic Equipment Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Australia
  • India

Ophthalmic Diagnostic Equipment Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • NMPA
  • TGA
  • ICAC

Scope

This report provides:

  • Extensive coverage of the Ophthalmic Diagnostic Equipment under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of ophthalmic diagnostic equipment and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report will enable you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of ophthalmic diagnostic equipment under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

AcuMEMS
Adom Advanced Optical Technologies Ltd
Aeon Imaging, LLC
AEYE Health
AI Optics Inc
Aireen as
Alcon Inc
ArcScan, Inc.
Atlanta VA Medical Center
Avedro Inc
Babel Analytics LLC
Bar-Ilan University
Baylor College of Medicine
Beaver-Visitec International Inc
Beijing Airdoc Technology Co Ltd
Ben-Gurion University of the Negev
Beth Israel Deaconess Medical Center
BioFormatix, Inc.
Bioinformative Institute of India
Biolight Engineering LLC
Boston Micromachines Corporation
Brien Holden Vision Institute
Broadspot Imaging Corp
C&V Tech Inc
Cambridge University Hospitals NHS Foundation Trust
Canon USA Inc
Cardiff University
Carl Zeiss AG
Case Western Reserve University
CeeMax Ophthalmics
Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine
ChromoLogic LLC
Coland Holdings Limited
Columbia University
Compact Imaging Inc.
Costruzioni Strumenti Oftalmici Cso Srl
CW Optics Inc
Dalhousie University
DigitalVision, LLC
Duke University
Duke-NUS Graduate Medical School
EarlySight SA
El-Vision Ltd.
Enlighten Imaging Pty Ltd
Epvsensors, LLC
Eye Care and Cure
Eye Marker Systems Inc (Inactive)
eyeMITRA
Eyenuk Inc.
EyeQue Corp
Eyoto Group Ltd
Fovioptics, Inc. (Inactive)
Gaush Meditech Ltd
Gemss Co.,Ltd.
George Washington University
GlakoLens Biyomedikal Biyoteknoloji San ve Tic AS
Hadasit Medical Research Services and Development Ltd
Hadassah Medical Center
H-Cubed Inc.
Hedgefog Research Inc
Heidelberg Engineering GmbH
Heriot-Watt University
Hong Kong Polytechnic University
IDx LLC
I-MED Pharma Inc
Imperial College London
Implandata Ophthalmic Products GmbH
Indian Institute of Technology Delhi
Intelon Optics, Inc
i-Optics BV
iSonic Medical
Johns Hopkins University
Kaleyedos
Kowa Co Ltd
Kubota Vision Inc
LaunchPoint Technologies Inc
Leica Microsystems GmbH
LighTopTech Corp
Loughborough University
LucyDx LLC
Lumedica Inc
Lumetrics Inc
Lumisoft Technologies Pvt Ltd
Lygent Inc
MacCure
Massachusetts Eye and Ear Infirmary
Medical University of South Carolina
Michigan State University
MicroPort Scientific Corp
Moorfields Eye Hospital NHS Foundation Trust
Nagasaki University
National Taiwan University Hospital
National University Hospital
National University of Singapore
Neuro Kinetics Inc
NeuroFieldz Inc
Neurolens Inc
Neuroptics Inc.
Next Dimension Ltd.
nGoggle Inc
Nippon Telegraph and Telephone Corp
Notal Vision Inc
Nova Southeastern University
NovaSight
Objective Acuity Ltd
Occuity Ltd
OcuSciences, Inc.
Ocutronics, LLC
oDocs Eye Care Ltd
Ohio State University
Oivi AS
OKO Icare Solutions Pvt Ltd
Ophthalmic Sciences Ltd
Opticent Inc
Optomed Oy
OptoQuest Inc
Optos Plc
OptoVibronex LLC
Optovue Inc
Oregon Health & Science University
Oxford University Innovation Ltd
PAIR Technologies LLC
Paradigm Medical Industries, Inc. (Inactive)
PeriVision
Physical Sciences Inc
PlenOptica Inc
Predictek Inc
Profundus AB
REBIScan Inc
Regensight Srl
Reichert Inc
Rensselaer Polytechnic Institute
RetinalGenix, Inc.
Retinostics
RetinScan
RetInSight GmbH
Retispec Inc
Reyedar BV
Rice University
Rowiak GmbH
Rutgers The State University of New Jersey
Scalar Bioscience, LLC
Schepens Eye Research Institute
Shenzhen Sibionics Technology Co Ltd
Shiwei Yingxiang
Singapore Eye Research Institute
Singapore National Eye Centre
Sinoora Inc.
SOLX Inc
Stanford University
Stellenbosch University
Structured Eye Ltd
SynCore Biotechnology Co Ltd
Tear Diagno LLC (Inactive)
TeleMedC Pte Ltd
Tesseract Health Inc
The Chaim Sheba Medical Center
The Chinese University of Hong Kong
The Wilmer Eye Institute at Johns Hopkins
Theia Imaging LLC
Tishyas Medical Device Development Solutions Pvt Ltd
Tissot Medical Research SA
Ti-TaMed (PTY) LTD.
TonoGuard Ltd.
Tonomy
Trivitron Healthcare Pvt Ltd
Tufts University
Tupai (Beijing) Medical Technology Co Ltd
UltraVision CLPL
University College London
University Hospital Bonn
University of Arizona
University of Auckland
University of Bern
University of California Berkeley
University of California Davis
University of California Los Angeles
University of California San Diego
University of California San Francisco
University of Colorado
University of Edinburgh
University of Galway
University of Illinois
University of Illinois at Chicago
University of Liverpool
University of Louisville
University of Malaya
University of Melbourne
University of Michigan Kellogg Eye Center
University of Pecs
University of Pittsburgh
University of Rochester
University of South Florida
University of Southern California
University of Strathclyde
University of Texas at Austin
University of Texas Southwestern Medical Center
University of Toronto
University of Utah
University of Valencia
University of Washington
Vanderbilt University
Vasoptic Medical, Inc.
Vision Instruments Pty. Ltd.
VisionQuest Biomedical LLC
Visual Pathways, Inc. (Inactive)
ViVO Smart Medical Devices Ltd
Welch Allyn Inc
West Virginia University
Yaoshi (Suzhou) Medical Technology Co Ltd
Ziemer Ophthalmic Systems AG

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 13

|1.2 List of Figures 29

2 Introduction 30

2.1 Ophthalmic Diagnostic Equipment Overview 30

3 Products under Development 31

3.1 Ophthalmic Diagnostic Equipment – Pipeline Products by Stage of Development 31

3.2 Ophthalmic Diagnostic Equipment – Pipeline Products by Segment 32

3.3 Ophthalmic Diagnostic Equipment – Pipeline Products by Territory 33

3.4 Ophthalmic Diagnostic Equipment – Pipeline Products by Regulatory Path 35

3.5 Ophthalmic Diagnostic Equipment – Pipeline Products by Estimated Approval Date 36

3.6 Ophthalmic Diagnostic Equipment – Ongoing Clinical Trials 37

4 Ophthalmic Diagnostic Equipment – Pipeline Products under Development by Companies 38

4.1 Ophthalmic Diagnostic Equipment Companies – Pipeline Products by Stage of Development 38

4.2 Ophthalmic Diagnostic Equipment – Pipeline Products by Stage of Development 46

5 Ophthalmic Diagnostic Equipment Companies and Product Overview 53

5.1 AcuMEMS Company Overview 53

5.1.1 AcuMEMS Pipeline Products & Ongoing Clinical Trials Overview 53

5.2 Adom Advanced Optical Technologies Ltd Company Overview 56

5.2.1 Adom Advanced Optical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

5.3 Aeon Imaging, LLC Company Overview 59

5.3.1 Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 59

5.4 AEYE Health Company Overview 62

5.4.1 AEYE Health Pipeline Products & Ongoing Clinical Trials Overview 62

5.5 AI Optics Inc Company Overview 63

5.5.1 AI Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.6 Aireen as Company Overview 64

5.6.1 Aireen as Pipeline Products & Ongoing Clinical Trials Overview 64

5.7 Alcon Inc Company Overview 66

5.7.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 66

5.8 ArcScan, Inc. Company Overview 68

5.8.1 ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

5.9 Atlanta VA Medical Center Company Overview 69

5.9.1 Atlanta VA Medical Center Pipeline Products & Ongoing Clinical Trials Overview 69

5.10 Avedro Inc Company Overview 70

5.10.1 Avedro Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.11 Babel Analytics LLC Company Overview 71

5.11.1 Babel Analytics LLC Pipeline Products & Ongoing Clinical Trials Overview 71

5.12 Bar-Ilan University Company Overview 72

5.12.1 Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 72

5.13 Baylor College of Medicine Company Overview 73

5.13.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 73

5.14 Beaver-Visitec International Inc Company Overview 74

5.14.1 Beaver-Visitec International Inc Pipeline Products & Ongoing Clinical Trials Overview 74

5.15 Beijing Airdoc Technology Co Ltd Company Overview 76

5.15.1 Beijing Airdoc Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 76

5.16 Ben-Gurion University of the Negev Company Overview 78

5.16.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 78

5.17 Beth Israel Deaconess Medical Center Company Overview 79

5.17.1 Beth Israel Deaconess Medical Center Pipeline Products & Ongoing Clinical Trials Overview 79

5.18 BioFormatix, Inc. Company Overview 80

5.18.1 BioFormatix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80

5.19 Bioinformative Institute of India Company Overview 81

5.19.1 Bioinformative Institute of India Pipeline Products & Ongoing Clinical Trials Overview 81

5.20 Biolight Engineering LLC Company Overview 82

5.20.1 Biolight Engineering LLC Pipeline Products & Ongoing Clinical Trials Overview 82

5.21 Boston Micromachines Corporation Company Overview 83

5.21.1 Boston Micromachines Corporation Pipeline Products & Ongoing Clinical Trials Overview 83

5.22 Brien Holden Vision Institute Company Overview 84

5.22.1 Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview 84

5.23 Broadspot Imaging Corp Company Overview 85

5.23.1 Broadspot Imaging Corp Pipeline Products & Ongoing Clinical Trials Overview 85

5.24 C&V Tech Inc Company Overview 86

5.24.1 C&V Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.25 Cambridge University Hospitals NHS Foundation Trust Company Overview 87

5.25.1 Cambridge University Hospitals NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 87

5.26 Canon USA Inc Company Overview 90

5.26.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.27 Cardiff University Company Overview 92

5.27.1 Cardiff University Pipeline Products & Ongoing Clinical Trials Overview 92

5.28 Carl Zeiss AG Company Overview 93

5.28.1 Carl Zeiss AG Pipeline Products & Ongoing Clinical Trials Overview 93

5.29 Case Western Reserve University Company Overview 94

5.29.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 94

5.30 CeeMax Ophthalmics Company Overview 96

5.30.1 CeeMax Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview 96

5.31 Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Company Overview 97

5.31.1 Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Pipeline Products & Ongoing Clinical Trials Overview 97

5.32 ChromoLogic LLC Company Overview 99

5.32.1 ChromoLogic LLC Pipeline Products & Ongoing Clinical Trials Overview 99

5.33 Coland Holdings Limited Company Overview 100

5.33.1 Coland Holdings Limited Pipeline Products & Ongoing Clinical Trials Overview 100

5.34 Columbia University Company Overview 102

5.34.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 102

5.35 Compact Imaging Inc. Company Overview 103

5.35.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 103

5.36 Costruzioni Strumenti Oftalmici Cso Srl Company Overview 104

5.36.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 104

5.37 CW Optics Inc Company Overview 105

5.37.1 CW Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 105

5.38 Dalhousie University Company Overview 106

5.38.1 Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview 106

5.39 DigitalVision, LLC Company Overview 107

5.39.1 DigitalVision, LLC Pipeline Products & Ongoing Clinical Trials Overview 107

5.40 Duke University Company Overview 108

5.40.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 108

5.41 Duke-NUS Graduate Medical School Company Overview 116

5.41.1 Duke-NUS Graduate Medical School Pipeline Products & Ongoing Clinical Trials Overview 116

5.42 EarlySight SA Company Overview 117

5.42.1 EarlySight SA Pipeline Products & Ongoing Clinical Trials Overview 117

5.43 El-Vision Ltd. Company Overview 118

5.43.1 El-Vision Ltd. Pipeline Products & Ongoing Clinical Trials Overview 118

5.44 Enlighten Imaging Pty Ltd Company Overview 119

5.44.1 Enlighten Imaging Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 119

5.45 Epvsensors, LLC Company Overview 120

5.45.1 Epvsensors, LLC Pipeline Products & Ongoing Clinical Trials Overview 120

5.46 Eye Care and Cure Company Overview 122

5.46.1 Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 122

5.47 Eye Marker Systems Inc (Inactive) Company Overview 123

5.47.1 Eye Marker Systems Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 123

5.48 eyeMITRA Company Overview 124

5.48.1 eyeMITRA Pipeline Products & Ongoing Clinical Trials Overview 124

5.49 Eyenuk Inc. Company Overview 125

5.49.1 Eyenuk Inc. Pipeline Products & Ongoing Clinical Trials Overview 125

5.50 EyeQue Corp Company Overview 126

5.50.1 EyeQue Corp Pipeline Products & Ongoing Clinical Trials Overview 126

5.51 Eyoto Group Ltd Company Overview 129

5.51.1 Eyoto Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 129

5.52 Fovioptics, Inc. (Inactive) Company Overview 131

5.52.1 Fovioptics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 131

5.53 Gaush Meditech Ltd Company Overview 132

5.53.1 Gaush Meditech Ltd Pipeline Products & Ongoing Clinical Trials Overview 132

5.54 Gemss Co.,Ltd. Company Overview 133

5.54.1 Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 133

5.55 George Washington University Company Overview 134

5.55.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 134

5.56 GlakoLens Biyomedikal Biyoteknoloji San ve Tic AS Company Overview 136

5.56.1 GlakoLens Biyomedikal Biyoteknoloji San ve Tic AS Pipeline Products & Ongoing Clinical Trials Overview 136

5.57 Hadasit Medical Research Services and Development Ltd Company Overview 137

5.57.1 Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 137

5.58 Hadassah Medical Center Company Overview 138

5.58.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 138

5.59 H-Cubed Inc. Company Overview 139

5.59.1 H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview 139

5.60 Hedgefog Research Inc Company Overview 140

5.60.1 Hedgefog Research Inc Pipeline Products & Ongoing Clinical Trials Overview 140

5.61 Heidelberg Engineering GmbH Company Overview 141

5.61.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 141

5.62 Heriot-Watt University Company Overview 146

5.62.1 Heriot-Watt University Pipeline Products & Ongoing Clinical Trials Overview 146

5.63 Hong Kong Polytechnic University Company Overview 147

5.63.1 Hong Kong Polytechnic University Pipeline Products & Ongoing Clinical Trials Overview 147

5.64 IDx LLC Company Overview 148

5.64.1 IDx LLC Pipeline Products & Ongoing Clinical Trials Overview 148

5.65 I-MED Pharma Inc Company Overview 149

5.65.1 I-MED Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 149

5.66 Imperial College London Company Overview 150

5.66.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 150

5.67 Implandata Ophthalmic Products GmbH Company Overview 151

5.67.1 Implandata Ophthalmic Products GmbH Pipeline Products & Ongoing Clinical Trials Overview 151

5.68 Indian Institute of Technology Delhi Company Overview 154

5.68.1 Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview 154

5.69 Intelon Optics, Inc Company Overview 155

5.69.1 Intelon Optics, Inc Pipeline Products & Ongoing Clinical Trials Overview 155

5.70 i-Optics BV Company Overview 156

5.70.1 i-Optics BV Pipeline Products & Ongoing Clinical Trials Overview 156

5.71 iSonic Medical Company Overview 158

5.71.1 iSonic Medical Pipeline Products & Ongoing Clinical Trials Overview 158

5.72 Johns Hopkins University Company Overview 159

5.72.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 159

5.73 Kaleyedos Company Overview 160

5.73.1 Kaleyedos Pipeline Products & Ongoing Clinical Trials Overview 160

5.74 Kowa Co Ltd Company Overview 161

5.74.1 Kowa Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 161

5.75 Kubota Vision Inc Company Overview 163

5.75.1 Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 163

5.76 LaunchPoint Technologies Inc Company Overview 166

5.76.1 LaunchPoint Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 166

5.77 Leica Microsystems GmbH Company Overview 167

5.77.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 167

5.78 LighTopTech Corp Company Overview 169

5.78.1 LighTopTech Corp Pipeline Products & Ongoing Clinical Trials Overview 169

5.79 Loughborough University Company Overview 170

5.79.1 Loughborough University Pipeline Products & Ongoing Clinical Trials Overview 170

5.80 LucyDx LLC Company Overview 171

5.80.1 LucyDx LLC Pipeline Products & Ongoing Clinical Trials Overview 171

5.81 Lumedica Inc Company Overview 172

5.81.1 Lumedica Inc Pipeline Products & Ongoing Clinical Trials Overview 172

5.82 Lumetrics Inc Company Overview 174

5.82.1 Lumetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 174

5.83 Lumisoft Technologies Pvt Ltd Company Overview 176

5.83.1 Lumisoft Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 176

5.84 Lygent Inc Company Overview 178

5.84.1 Lygent Inc Pipeline Products & Ongoing Clinical Trials Overview 178

5.85 MacCure Company Overview 179

5.85.1 MacCure Pipeline Products & Ongoing Clinical Trials Overview 179

5.86 Massachusetts Eye and Ear Infirmary Company Overview 180

5.86.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 180

5.87 Medical University of South Carolina Company Overview 182

5.87.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 182

5.88 Michigan State University Company Overview 183

5.88.1 Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 183

5.89 MicroPort Scientific Corp Company Overview 184

5.89.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 184

5.90 Moorfields Eye Hospital NHS Foundation Trust Company Overview 185

5.90.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 185

5.91 Nagasaki University Company Overview 186

5.91.1 Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 186

5.92 National Taiwan University Hospital Company Overview 187

5.92.1 National Taiwan University Hospital Pipeline Products & Ongoing Clinical Trials Overview 187

5.93 National University Hospital Company Overview 188

5.93.1 National University Hospital Pipeline Products & Ongoing Clinical Trials Overview 188

5.94 National University of Singapore Company Overview 189

5.94.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 189

5.95 Neuro Kinetics Inc Company Overview 190

5.95.1 Neuro Kinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 190

5.96 NeuroFieldz Inc Company Overview 191

5.96.1 NeuroFieldz Inc Pipeline Products & Ongoing Clinical Trials Overview 191

5.97 Neurolens Inc Company Overview 192

5.97.1 Neurolens Inc Pipeline Products & Ongoing Clinical Trials Overview 192

5.98 Neuroptics Inc. Company Overview 193

5.98.1 Neuroptics Inc. Pipeline Products & Ongoing Clinical Trials Overview 193

5.99 Next Dimension Ltd. Company Overview 194

5.99.1 Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview 194

5.100 nGoggle Inc Company Overview 195

5.100.1 nGoggle Inc Pipeline Products & Ongoing Clinical Trials Overview 195

5.101 Nippon Telegraph and Telephone Corp Company Overview 198

5.101.1 Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview 198

5.102 Notal Vision Inc Company Overview 199

5.102.1 Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 199

5.103 Nova Southeastern University Company Overview 203

5.103.1 Nova Southeastern University Pipeline Products & Ongoing Clinical Trials Overview 203

5.104 NovaSight Company Overview 204

5.104.1 NovaSight Pipeline Products & Ongoing Clinical Trials Overview 204

5.105 Objective Acuity Ltd Company Overview 207

5.105.1 Objective Acuity Ltd Pipeline Products & Ongoing Clinical Trials Overview 207

5.106 Occuity Ltd Company Overview 208

5.106.1 Occuity Ltd Pipeline Products & Ongoing Clinical Trials Overview 208

5.107 OcuSciences, Inc. Company Overview 210

5.107.1 OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 210

5.108 Ocutronics, LLC Company Overview 211

5.108.1 Ocutronics, LLC Pipeline Products & Ongoing Clinical Trials Overview 211

5.109 oDocs Eye Care Ltd Company Overview 212

5.109.1 oDocs Eye Care Ltd Pipeline Products & Ongoing Clinical Trials Overview 212

5.110 Ohio State University Company Overview 214

5.110.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 214

5.111 Oivi AS Company Overview 215

5.111.1 Oivi AS Pipeline Products & Ongoing Clinical Trials Overview 215

5.112 OKO Icare Solutions Pvt Ltd Company Overview 216

5.112.1 OKO Icare Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 216

5.113 Ophthalmic Sciences Ltd Company Overview 217

5.113.1 Ophthalmic Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 217

5.114 Opticent Inc Company Overview 219

5.114.1 Opticent Inc Pipeline Products & Ongoing Clinical Trials Overview 219

5.115 Optomed Oy Company Overview 221

5.115.1 Optomed Oy Pipeline Products & Ongoing Clinical Trials Overview 221

5.116 OptoQuest Inc Company Overview 223

5.116.1 OptoQuest Inc Pipeline Products & Ongoing Clinical Trials Overview 223

5.117 Optos Plc Company Overview 224

5.117.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 224

5.118 OptoVibronex LLC Company Overview 232

5.118.1 OptoVibronex LLC Pipeline Products & Ongoing Clinical Trials Overview 232

5.119 Optovue Inc Company Overview 233

5.119.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 233

5.120 Oregon Health & Science University Company Overview 234

5.120.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 234

5.121 Oxford University Innovation Ltd Company Overview 235

5.121.1 Oxford University Innovation Ltd Pipeline Products & Ongoing Clinical Trials Overview 235

5.122 PAIR Technologies LLC Company Overview 236

5.122.1 PAIR Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 236

5.123 Paradigm Medical Industries, Inc. (Inactive) Company Overview 237

5.123.1 Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 237

5.124 PeriVision Company Overview 238

5.124.1 PeriVision Pipeline Products & Ongoing Clinical Trials Overview 238

5.125 Physical Sciences Inc Company Overview 239

5.125.1 Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 239

5.126 PlenOptica Inc Company Overview 241

5.126.1 PlenOptica Inc Pipeline Products & Ongoing Clinical Trials Overview 241

5.127 Predictek Inc Company Overview 242

5.127.1 Predictek Inc Pipeline Products & Ongoing Clinical Trials Overview 242

5.128 Profundus AB Company Overview 243

5.128.1 Profundus AB Pipeline Products & Ongoing Clinical Trials Overview 243

5.129 REBIScan Inc Company Overview 244

5.129.1 REBIScan Inc Pipeline Products & Ongoing Clinical Trials Overview 244

5.130 Regensight Srl Company Overview 248

5.130.1 Regensight Srl Pipeline Products & Ongoing Clinical Trials Overview 248

5.131 Reichert Inc Company Overview 251

5.131.1 Reichert Inc Pipeline Products & Ongoing Clinical Trials Overview 251

5.132 Rensselaer Polytechnic Institute Company Overview 254

5.132.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 254

5.133 RetinalGenix, Inc. Company Overview 255

5.133.1 RetinalGenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 255

5.134 Retinostics Company Overview 256

5.134.1 Retinostics Pipeline Products & Ongoing Clinical Trials Overview 256

5.135 RetinScan Company Overview 257

5.135.1 RetinScan Pipeline Products & Ongoing Clinical Trials Overview 257

5.136 RetInSight GmbH Company Overview 258

5.136.1 RetInSight GmbH Pipeline Products & Ongoing Clinical Trials Overview 258

5.137 Retispec Inc Company Overview 259

5.137.1 Retispec Inc Pipeline Products & Ongoing Clinical Trials Overview 259

5.138 Reyedar BV Company Overview 260

5.138.1 Reyedar BV Pipeline Products & Ongoing Clinical Trials Overview 260

5.139 Rice University Company Overview 261

5.139.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 261

5.140 Rowiak GmbH Company Overview 262

5.140.1 Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview 262

5.141 Rutgers The State University of New Jersey Company Overview 263

5.141.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 263

5.142 Scalar Bioscience, LLC Company Overview 264

5.142.1 Scalar Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview 264

5.143 Schepens Eye Research Institute Company Overview 265

5.143.1 Schepens Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview 265

5.144 Shenzhen Sibionics Technology Co Ltd Company Overview 266

5.144.1 Shenzhen Sibionics Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 266

5.145 Shiwei Yingxiang Company Overview 267

5.145.1 Shiwei Yingxiang Pipeline Products & Ongoing Clinical Trials Overview 267

5.146 Singapore Eye Research Institute Company Overview 270

5.146.1 Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview 270

5.147 Singapore National Eye Centre Company Overview 272

5.147.1 Singapore National Eye Centre Pipeline Products & Ongoing Clinical Trials Overview 272

5.148 Sinoora Inc. Company Overview 273

5.148.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 273

5.149 SOLX Inc Company Overview 274

5.149.1 SOLX Inc Pipeline Products & Ongoing Clinical Trials Overview 274

5.150 Stanford University Company Overview 275

5.150.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 275

5.151 Stellenbosch University Company Overview 276

5.151.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 276

5.152 Structured Eye Ltd Company Overview 277

5.152.1 Structured Eye Ltd Pipeline Products & Ongoing Clinical Trials Overview 277

5.153 SynCore Biotechnology Co Ltd Company Overview 278

5.153.1 SynCore Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 278

5.154 Tear Diagno LLC (Inactive) Company Overview 279

5.154.1 Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 279

5.155 TeleMedC Pte Ltd Company Overview 280

5.155.1 TeleMedC Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 280

5.156 Tesseract Health Inc Company Overview 285

5.156.1 Tesseract Health Inc Pipeline Products & Ongoing Clinical Trials Overview 285

5.157 The Chaim Sheba Medical Center Company Overview 286

5.157.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 286

5.158 The Chinese University of Hong Kong Company Overview 287

5.158.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 287

5.159 The Wilmer Eye Institute at Johns Hopkins Company Overview 288

5.159.1 The Wilmer Eye Institute at Johns Hopkins Pipeline Products & Ongoing Clinical Trials Overview 288

5.160 Theia Imaging LLC Company Overview 291

5.160.1 Theia Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 291

5.161 Tishyas Medical Device Development Solutions Pvt Ltd Company Overview 296

5.161.1 Tishyas Medical Device Development Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 296

5.162 Tissot Medical Research SA Company Overview 297

5.162.1 Tissot Medical Research SA Pipeline Products & Ongoing Clinical Trials Overview 297

5.163 Ti-TaMed (PTY) LTD. Company Overview 298

5.163.1 Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview 298

5.164 TonoGuard Ltd. Company Overview 299

5.164.1 TonoGuard Ltd. Pipeline Products & Ongoing Clinical Trials Overview 299

5.165 Tonomy Company Overview 300

5.165.1 Tonomy Pipeline Products & Ongoing Clinical Trials Overview 300

5.166 Trivitron Healthcare Pvt Ltd Company Overview 301

5.166.1 Trivitron Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 301

5.167 Tufts University Company Overview 302

5.167.1 Tufts University Pipeline Products & Ongoing Clinical Trials Overview 302

5.168 Tupai (Beijing) Medical Technology Co Ltd Company Overview 303

5.168.1 Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 303

5.169 UltraVision CLPL Company Overview 306

5.169.1 UltraVision CLPL Pipeline Products & Ongoing Clinical Trials Overview 306

5.170 University College London Company Overview 307

5.170.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 307

5.171 University Hospital Bonn Company Overview 308

5.171.1 University Hospital Bonn Pipeline Products & Ongoing Clinical Trials Overview 308

5.172 University of Arizona Company Overview 309

5.172.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 309

5.173 University of Auckland Company Overview 312

5.173.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 312

5.174 University of Bern Company Overview 313

5.174.1 University of Bern Pipeline Products & Ongoing Clinical Trials Overview 313

5.175 University of California Berkeley Company Overview 314

5.175.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 314

5.176 University of California Davis Company Overview 316

5.176.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 316

5.177 University of California Los Angeles Company Overview 317

5.177.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 317

5.178 University of California San Diego Company Overview 319

5.178.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 319

5.179 University of California San Francisco Company Overview 320

5.179.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 320

5.180 University of Colorado Company Overview 321

5.180.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 321

5.181 University of Edinburgh Company Overview 322

5.181.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 322

5.182 University of Galway Company Overview 323

5.182.1 University of Galway Pipeline Products & Ongoing Clinical Trials Overview 323

5.183 University of Illinois Company Overview 324

5.183.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 324

5.184 University of Illinois at Chicago Company Overview 325

5.184.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 325

5.185 University of Liverpool Company Overview 328

5.185.1 University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview 328

5.186 University of Louisville Company Overview 329

5.186.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 329

5.187 University of Malaya Company Overview 330

5.187.1 University of Malaya Pipeline Products & Ongoing Clinical Trials Overview 330

5.188 University of Melbourne Company Overview 331

5.188.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 331

5.189 University of Michigan Kellogg Eye Center Company Overview 332

5.189.1 University of Michigan Kellogg Eye Center Pipeline Products & Ongoing Clinical Trials Overview 332

5.190 University of Pecs Company Overview 333

5.190.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 333

5.191 University of Pittsburgh Company Overview 334

5.191.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 334

5.192 University of Rochester Company Overview 336

5.192.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 336

5.193 University of South Florida Company Overview 337

5.193.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 337

5.194 University of Southern California Company Overview 339

5.194.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 339

5.195 University of Strathclyde Company Overview 340

5.195.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 340

5.196 University of Texas at Austin Company Overview 341

5.196.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 341

5.197 University of Texas Southwestern Medical Center Company Overview 342

5.197.1 University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview 342

5.198 University of Toronto Company Overview 343

5.198.1 University of Toronto Pipeline Products & Ongoing Clinical Trials Overview 343

5.199 University of Utah Company Overview 344

5.199.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 344

5.200 University of Valencia Company Overview 345

5.200.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 345

5.201 University of Washington Company Overview 347

5.201.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 347

5.202 Vanderbilt University Company Overview 348

5.202.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 348

5.203 Vasoptic Medical, Inc. Company Overview 349

5.203.1 Vasoptic Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 349

5.204 Vision Instruments Pty. Ltd. Company Overview 353

5.204.1 Vision Instruments Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 353

5.205 VisionQuest Biomedical LLC Company Overview 354

5.205.1 VisionQuest Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview 354

5.206 Visual Pathways, Inc. (Inactive) Company Overview 357

5.206.1 Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 357

5.207 ViVO Smart Medical Devices Ltd Company Overview 361

5.207.1 ViVO Smart Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 361

5.208 Welch Allyn Inc Company Overview 362

5.208.1 Welch Allyn Inc Pipeline Products & Ongoing Clinical Trials Overview 362

5.209 West Virginia University Company Overview 364

5.209.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 364

5.210 Yaoshi (Suzhou) Medical Technology Co Ltd Company Overview 365

5.210.1 Yaoshi (Suzhou) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 365

5.211 Ziemer Ophthalmic Systems AG Company Overview 367

5.211.1 Ziemer Ophthalmic Systems AG Pipeline Products & Ongoing Clinical Trials Overview 367

6 Ophthalmic Diagnostic Equipment- Recent Developments 368

6.1 Dec 08, 2023: Zilia Receives 510(K) Clearance For Zilia Ocular FC (ZIL-10002) 368

6.2 Nov 29, 2023: Zilia Receives FDA Clearance for Its Zilia Ocular FC Retinal Camera 368

6.3 Nov 21, 2023: Revenio Group Announces Financial Reporting and AGM in 2024 368

6.4 Nov 15, 2023: Topcon Medical Systems Receives 510(K) Clearance For Maestro2 368

6.5 Nov 10, 2023: Huvitz Receives 510(K) Clearance For Applanation Tonometer HT-5000 369

6.6 Nov 08, 2023: RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam Image Visualization Device 369

6.7 Nov 05, 2023: Heidelberg Engineering Receives Additional 510(K) Clearance for Spectralis HRA+OCT 369

6.8 Nov 03, 2023: Optomed Announces Interim Report, January – September 2023 369

6.9 Oct 27, 2023: Aeye Health and Topcon Screen Announce Partnership to Enhance Point-Of-Care Diabetic Retinopathy Screening with Best-In-Class AI Technology 370

6.10 Oct 26, 2023: Revenio Group Corporation: Interim report January 1 – September 30, 2023 371

6.11 Oct 24, 2023: Implandata Announces Appointment of New Members Dr. Adrienne Graves and Jan Willem de Cler to Join Board of Directors 373

6.12 Oct 13, 2023: Heidelberg Engineering Announces FDA Clearance for All-in-One ANTERION Platform 373

6.13 Oct 02, 2023: Marco Rizzardo appointed as Vice President, R&D and a member of the Leadership Team of Revenio Group 374

6.14 Sep 21, 2023: Neolight Receives 510(k) Clearance for Phoenix ICON GO Imaging System 374

6.15 Sep 18, 2023: Retinalgenix Technologies Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases 375

6.16 Sep 08, 2023: Ocean Insight Names Richard Curran as President 375

6.17 Sep 07, 2023: New Multicenter Study Reveals Neurological Pupil Index (NPi) As Predictor of Outcome and Mortality in Brain Injury Patients 376

6.18 Sep 07, 2023: Canon Makes Director Changes 376

6.19 Sep 05, 2023: Optos Receives an Additional 510(k) Clearance for P200TE 376

6.20 Sep 05, 2023: Bruker’s New NeuraLeap Delivers Unprecedented Imaging Speed Across Optical Planes 377

6.21 Aug 15, 2023: Alcon Reports Second Quarter 2023 Results 377

6.22 Aug 10, 2023: Revenio Group Announces Half-Year Financial Report 1 January–30 June 2023 383

6.23 Aug 03, 2023: Juho Himberg has been appointed CEO of Optomed 391

6.24 Jul 31, 2023: RetinalGeniX’s patient home monitoring system receives patent 392

6.25 Jul 12, 2023: VISIA Imaging Receives Additional 510(k) Clearance for MYAH – Corneal Topography System 392

6.26 Jul 11, 2023: IRIS and AEYE Health Announce Partnership to Provide AI Screening to Market 393

6.27 Jun 22, 2023: New FDA Clearance Makes Eyenuk the First Company with Multiple Cameras

Table

Ophthalmic Diagnostic Equipment – Pipeline Products by Stage of Development 31

Ophthalmic Diagnostic Equipment – Pipeline Products by Segment 32

Ophthalmic Diagnostic Equipment – Pipeline Products by Territory 33

Ophthalmic Diagnostic Equipment – Pipeline Products by Regulatory Path 35

Ophthalmic Diagnostic Equipment – Pipeline Products by Estimated Approval Date 36

Ophthalmic Diagnostic Equipment – Ongoing Clinical Trials 37

Ophthalmic Diagnostic Equipment Companies – Pipeline Products by Stage of Development 38

Ophthalmic Diagnostic Equipment – Pipeline Products by Stage of Development 46

AcuMEMS Pipeline Products & Ongoing Clinical Trials Overview 53

IOP Sensor – Anterior Chamber – Product Status 53

IOP Sensor – Anterior Chamber – Product Description 53

IOP Sensor – Posterior Chamber – Product Status 54

IOP Sensor – Posterior Chamber – Product Description 54

iSense System – Product Status 54

iSense System – Product Description 55

Adom Advanced Optical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 56

Tear Film Imager (TFI) – COVID-19 – Product Status 56

Tear Film Imager (TFI) – COVID-19 – Product Description 56

Adom Advanced Optical Technologies Ltd – Ongoing Clinical Trials Overview 57

Tear Film Imager (TFI) – COVID-19 – Study to Compare the Efficacy of Tear Film Imager Versus Current Standard of Care for Detection of COVID-19 within the Surface of the Eye 58

Aeon Imaging, LLC Pipeline Products & Ongoing Clinical Trials Overview 59

Digital Light Ophthalmoscope (DLO) – Product Status 59

Digital Light Ophthalmoscope (DLO) – Product Description 59

Digital Light Ophthalmoscope Adaptive Optics System – Product Status 60

Digital Light Ophthalmoscope Adaptive Optics System – Product Description 60

Laser Scanning Digital Camera – Product Status 60

Laser Scanning Digital Camera – Product Description 61

Potential Vision Tester – Product Status 61

Potential Vision Tester – Product Description 61

AEYE Health Pipeline Products & Ongoing Clinical Trials Overview 62

Aurora AEYE – Product Status 62

Aurora AEYE – Product Description 62

AI Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Handheld Retinal Camera – Diabetic Retinopathy – Product Status 63

Handheld Retinal Camera – Diabetic Retinopathy – Product Description 63

Aireen as Pipeline Products & Ongoing Clinical Trials Overview 64

Aireen Diagnostic Scope – Age-Related Macular Degeneration – Product Status 64

Aireen Diagnostic Scope – Age-Related Macular Degeneration – Product Description 64

Aireen Diagnostic Scope – Glaucoma – Product Status 65

Aireen Diagnostic Scope – Glaucoma – Product Description 65

Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview 66

All-In-One Office Diagnostic Device – Product Status 66

All-In-One Office Diagnostic Device – Product Description 66

Next-Gen Diagnostic Device – Product Status 67

Next-Gen Diagnostic Device – Product Description 67

ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

Artemis 3 – Product Status 68

Artemis 3 – Product Description 68

Atlanta VA Medical Center Pipeline Products & Ongoing Clinical Trials Overview 69

Goggles – Retinal Disease – Product Status 69

Goggles – Retinal Disease – Product Description 69

Avedro Inc Pipeline Products & Ongoing Clinical Trials Overview 70

Brillouin Scanning Microscope – Product Status 70

Brillouin Scanning Microscope – Product Description 70

Babel Analytics LLC Pipeline Products & Ongoing Clinical Trials Overview 71

Intelligent Retinal Imaging System – Product Status 71

Intelligent Retinal Imaging System – Product Description 71

Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview 72

Intraocular Pressure Monitoring Device – Home Use – Product Status 72

Intraocular Pressure Monitoring Device – Home Use – Product Description 72

Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 73

HOCD Device – Product Status 73

HOCD Device – Product Description 73

Beaver-Visitec International Inc Pipeline Products & Ongoing Clinical Trials Overview 74

Leos – Product Status 74

Leos – Product Description 74

Miro – Product Status 75

Miro – Product Description 75

Beijing Airdoc Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 76

AI Portable Fundus Camera – Product Status 76

AI Portable Fundus Camera – Product Description 76

AI-FUNDUSCAMERA-M – Product Status 77

AI-FUNDUSCAMERA-M – Product Description 77

Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 78

Diagnostic Tool – Retinal Disorders – Product Status 78

Diagnostic Tool – Retinal Disorders – Product Description 78

Beth Israel Deaconess Medical Center Pipeline Products & Ongoing Clinical Trials Overview 79

Eye Movement Marker – Huntington’s Disease – Product Status 79

Eye Movement Marker – Huntington’s Disease – Product Description 79

BioFormatix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80

VirtualEye Perimeter – Product Status 80

VirtualEye Perimeter – Product Description 80

Bioinformative Institute of India Pipeline Products & Ongoing Clinical Trials Overview 81

Ocular Surface Disease Diagnostic System – Product Status 81

Ocular Surface Disease Diagnostic System – Product Description 81

Biolight Engineering LLC Pipeline Products & Ongoing Clinical Trials Overview 82

PedCam – Product Status 82

PedCam – Product Description 82

Boston Micromachines Corporation Pipeline Products & Ongoing Clinical Trials Overview 83

Next Generation Adaptive Optics Scanning Laser Ophthalmoscope – Product Status 83

Next Generation Adaptive Optics Scanning Laser Ophthalmoscope – Product Description 83

Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview 84

Advanced Retinal Imaging System – Product Status 84

Advanced Retinal Imaging System – Product Description 84

Broadspot Imaging Corp Pipeline Products & Ongoing Clinical Trials Overview 85

Ultrawidefield Imaging Device – Product Status 85

Ultrawidefield Imaging Device – Product Description 85

C&V Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 86

TONO-i Tonometer – Product Status 86

TONO-i Tonometer – Product Description 86

Cambridge University Hospitals NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 87

Neocam Digital Imaging Device – Product Status 87

Neocam Digital Imaging Device – Product Description 87

Cambridge University Hospitals NHS Foundation Trust – Ongoing Clinical Trials Overview 88

Neocam Digital Imaging Device – Can the Diagnostic Accuracy of Newborn Eye Screening for Congenital Cataract be Improved With Digital Dual Light Source Imaging? The Digital Imaging vs Ophthalmoscopy (DIvO)Study 89

Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 90

AOSLO (Adaptive Optics Scanning Laser Ophthalmoscopy) System – Product Status 90

AOSLO (Adaptive Optics Scanning Laser Ophthalmoscopy) System – Product Description 90

SPOCT HR – Product Status 91

SPOCT HR – Product Description 91

Cardiff University Pipeline Products & Ongoing Clinical Trials Overview 92

Retinal Densitometer – Product Status 92

Retinal Densitometer – Product Description 92

Carl Zeiss AG Pipeline Products & Ongoing Clinical Trials Overview 93

Multimodal Diagnostic System – Product Status 93

Multimodal Diagnostic System – Product Description 93

Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 94

3-D Microscopic Ultrasound System – Product Status 94

3-D Microscopic Ultrasound System – Product Description 94

Two-photon Ophthalmoscope – Product Status 95

Two-photon Ophthalmoscope – Product Description 95

CeeMax Ophthalmics Pipeline Products & Ongoing Clinical Trials Overview 96

In-Home Tonometer – Product Status 96

In-Home Tonometer – Product Description 96

Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine Pipeline Products & Ongoing Clinical Trials Overview 97

Lente Sensora – Product Status 97

Lente Sensora – Product Description 97

Sensing Contact Lens – Product Status 98

Sensing Contact Lens – Product Description 98

ChromoLogic LLC Pipeline Products & Ongoing Clinical Trials Overview 99

Ocular Flare Meter – Product Status 99

Ocular Flare Meter – Product Description 99

Coland Holdings Limited Pipeline Products & Ongoing Clinical Trials Overview 100

Ophthalmic Laser Scanning Fundus Photographic Instrument – Product Status 100

Ophthalmic Laser Scanning Fundus Photographic Instrument – Product Description 100

Portable Fundus Camera – Product Status 101

Portable Fundus Camera – Product Description 101

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 102

Photoacoustic Imaging System – Product Status 102

Photoacoustic Imaging System – Product Description 102

Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 103

MRO Optical Imaging Sensor – Product Status 103

MRO Optical Imaging Sensor – Product Description 103

Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 104

MD-SD-OCT Instrument – Product Status 104

MD-SD-OCT Instrument – Product Description 104

CW Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 105

RetinalImager – Product Status 105

RetinalImager – Product Description 105

Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview 106

Eye Imaging Device – Product Status 106

Eye Imaging Device – Product Description 106

DigitalVision, LLC Pipeline Products & Ongoing Clinical Trials Overview 107

VisionOptimizer – Product Status 107

VisionOptimizer – Product Description 107

Duke University Pipeline Products & Ongoing Clinical Trials Overview 108

HAOSLO – Product Status 108

HAOSLO – Product Description 108

HH – SDOCT – Product Status 109

HH – SDOCT – Product Description 109

Microscope Integrated OCT System – Product Status 109

Microscope Integrated OCT System – Product Description 110

OCT Scanner – Product Status 110

OCT Scanner – Product Description 110

Stereoscopic Heads-Up Display – Product Status 111

Stereoscopic Heads-Up Display – Product Description 111

Whole Eye Optical Coherence Tomography Scanner – Product Status 111

Whole Eye Optical Coherence Tomography Scanner – Product Description 112

Duke University – Ongoing Clinical Trials Overview 113

Microscope Integrated OCT System – Optimize Pediatric OCT (Optical Coherence Tomography) Imaging: a Pilot Study 114

Whole Eye Optical Coherence Tomography Scanner – Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 2 and School Age Follow on Study 115

Duke-NUS Graduate Medical School Pipeline Products & Ongoing Clinical Trials Overview 116

Pupillometer Device – Glaucoma Dx – Product Status 116

Pupillometer Device – Glaucoma Dx – Product Description 116

EarlySight SA Pipeline Products & Ongoing Clinical Trials Overview 117

Transscleral Retinal Imaging Device – Product Status 117

Transscleral Retinal Imaging Device – Product Description 117

El-Vision Ltd. Pipeline Products & Ongoing Clinical Trials Overview 118

OcuTest – Product Status 118

OcuTest – Product Description 118

Enlighten Imaging Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 119

Hyperspectral Retinal Imaging Camera – Product Status 119

Hyperspectral Retinal Imaging Camera – Product Description 119

Epvsensors, LLC Pipeline Products & Ongoing Clinical Trials Overview 120

Retinal Photometer – Product Status 120

Retinal Photometer – Product Description 120

Tactile Tonometer TT001 – Product Status 121

Tactile Tonometer TT001 – Product Description 121

Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview 122

Diagnostic Device – Eye Alignment – Product Status 122

Diagnostic Device – Eye Alignment – Product Description 122

Eye Marker Systems Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 123

RTD 1000 – Product Status 123

RTD 1000 – Product Description 123

eyeMITRA Pipeline Products & Ongoing Clinical Trials Overview 124

eyeMITRA Device – Product Status 124

eyeMITRA Device – Product Description 124

Eyenuk Inc. Pipeline Products & Ongoing Clinical Trials Overview 125

EyeSeeAMD – Product Status 125

EyeSeeAMD – Product Description 125

EyeQue Corp Pipeline Products & Ongoing Clinical Trials Overview 126

EQ103 – Product Status 126

EQ103 – Product Description 126

EyeQue Corp – Ongoing Clinical Trials Overview 127

EQ103 – An Exploratory Study in Healthy Adult Volunteers to Evaluate the Best Corrected Visual Acuity (BCVA) Performance of a Handheld Device Compared with a Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction 128

EQ103 – An Exploratory Study in Healthy Pediatric Volunteers to Evaluate the Performance of a Handheld Device Compared with Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction 128

Eyoto Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 129

Autorefractor – Product Status 129

Autorefractor – Product Description 129

Lensmeter – Desktop Version – Product Status 130

Lensmeter – Desktop Version – Product Description 130

Fovioptics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 131

Retinal Blood Analyzer – Product Status 131

Retinal Blood Analyzer – Product Description 131

Gaush Meditech Ltd Pipeline Products & Ongoing Clinical Trials Overview 132

Integrated Type Slit Lamp – Product Status 132

Integrated Type Slit Lamp – Product Description 132

Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 133

Motorized C-arm System – Product Status 133

Motorized C-arm System – Product Description 133

George Washington University Pipeline Products & Ongoing Clinical Trials Overview 134

Amplified Bimorph Scanning Mirror System – Product Status 134

Amplified Bimorph Scanning Mirror System – Product Description 134

iEye – Product Status 135

iEye – Product Description 135

GlakoLens Biyomedikal Biyoteknoloji San ve Tic AS Pipeline Products & Ongoing Clinical Trials Overview 136

IOP Sensor – Product Status 136

IOP Sensor – Product Description 136

Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 137

Automated Visual Acuity Device – Product Status 137

Automated Visual Acuity Device – Product Description 137

Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 138

Optic Neuritis Visual Test – Product Status 138

Optic Neuritis Visual Test – Product Description 138

H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview 139

Telemetric Microsensor – Product Status 139

Telemetric Microsensor – Product Description 139

Hedgefog Research Inc Pipeline Products & Ongoing Clinical Trials Overview 140

Ophthalmic Microendoscope – Product Status 140

Ophthalmic Microendoscope – Product Description 140

Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 141

Anterion – Product Status 141

Anterion – Product Description 141

Cataract And Refractive Imaging Device – Product Status 142

Cataract And Refractive Imaging Device – Product Description 142

SPECTRALIS OCT2 Module – OCT Angiography – Product Status 142

SPECTRALIS OCT2 Module – OCT Angiography – Product Description 143

Heidelberg Engineering GmbH – Ongoing Clinical Trials Overview 144

Anterion – Comparison of Three Swept-source Optical Coherence Biometry Devices in Long and Short Eyes 145

Heriot-Watt University Pipeline Products & Ongoing Clinical Trials Overview 146

Non-Invasive Cataract Diagnostic Tool – Product Status 146

Non-Invasive Cataract Diagnostic Tool – Product Description 146

Hong Kong Polytechnic University Pipeline Products & Ongoing Clinical Trials Overview 147

Diabetic Retinopathy Detection And Monitoring System – Product Status 147

Diabetic Retinopathy Detection And Monitoring System – Product Description 147

IDx LLC Pipeline Products & Ongoing Clinical Trials Overview 148

IDx – Glaucoma – Product Status 148

IDx – Glaucoma – Product Description 148

I-MED Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 149

i-Pen Second Generation – Product Status 149

i-Pen Second Generation – Product Description 149

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 150

Intraocular Wireless Pressure Sensing Implant – Product Status 150

Intraocular Wireless Pressure Sensing Implant – Product Description 150

Implandata Ophthalmic Products GmbH Pipeline Products & Ongoing Clinical Trials Overview 151

ARGOS-EO – Product Status 151

ARGOS-EO – Product Description 151

EYEMATE-IO – Product Status 152

EYEMATE-IO – Product Description 152

EYEMATE-SC – Product Status 152

EYEMATE-SC – Product Description 153

Indian Institute of Technology Delhi Pipeline Products & Ongoing Clinical Trials Overview 154

Fundus Imaging System – Diabetic Retinopathy – Product Status 154

Fundus Imaging System – Diabetic Retinopathy – Product Description 154

Intelon Optics, Inc Pipeline Products & Ongoing Clinical Trials Overview 155

Brillouin Optical Scanner – Product Status 155

Brillouin Optical Scanner – Product Description 155

i-Optics BV Pipeline Products & Ongoing Clinical Trials Overview 156

1KHz Retina Tracker – Product Status 156

1KHz Retina Tracker – Product Description 156

Superresolution Image Enhancement – Product Status 157

Superresolution Image Enhancement – Product Description 157

iSonic Medical Pipeline Products & Ongoing Clinical Trials Overview 158

Telemedical Homecare Tonometer – Product Status 158

Telemedical Homecare Tonometer – Product Description 158

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 159

Fundus Imaging System – Product Status 159

Fundus Imaging System – Product Description 159

Kaleyedos Pipeline Products & Ongoing Clinical Trials Overview 160

Wireless Retinal Imaging Device – Product Status 160

Wireless Retinal Imaging Device – Product Description 160

Kowa Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 161

VX-10a – Fundus Autofluorescence – Product Status 161

VX-10a – Fundus Autofluorescence – Product Description 162

Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 163

eyeMO – Product Status 163

eyeMO – Product Description 163

Kubota Vision Inc – Ongoing Clinical Trials Overview 164

eyeMO – A Prospective Study of Patient Based Ophthalmology Suite (PBOS), In-home Optical Coherence Tomography Device in Patients of Japan 165

LaunchPoint Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 166

Intraocular Pressure Sensor – Product Status 166

Intraocular Pressure Sensor – Product Description 166

Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 167

DI-SDOCT Imaging System – Product Status 167

DI-SDOCT Imaging System – Product Description 167

SDOCT Scanner – Product Status 168

SDOCT Scanner – Product Description 168

LighTopTech Corp Pipeline Products & Ongoing Clinical Trials Overview 169

Gabor-Domain Optical Coherence Microscopy Imaging System – Product Status 169

Gabor-Domain Optical Coherence Microscopy Imaging System – Product Description 169

Loughborough University Pipeline Products & Ongoing Clinical Trials Overview 170

Diagnostic Device – Keratoconus – Product Status 170

Diagnostic Device – Keratoconus – Product Description 170

LucyDx LLC Pipeline Products & Ongoing Clinical Trials Overview 171

Diagnostic Device – Diabetic Retinopathy – Product Status 171

Diagnostic Device – Diabetic Retinopathy – Product Description 171

Lumedica Inc Pipeline Products & Ongoing Clinical Trials Overview 172

OCTA System – Product Status 172

OCTA System – Product Description 172

Optical Coherence Tomography System – Product Status 173

Optical Coherence Tomography System – Product Description 173

Lumetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 174

Fiber-Optic Eye Measurement System – Product Status 174

Fiber-Optic Eye Measurement System – Product Description 174

Fundus Camera – Product Status 175

Fundus Camera – Product Description 175

Lumisoft Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 176

Digital Gonio Camera – Product Status 176

Digital Gonio Camera – Product Description 176

Digital Slit Lamp – Product Status 177

Digital Slit Lamp – Product Description 177

Lygent Inc Pipeline Products & Ongoing Clinical Trials Overview 178

iStrab – Product Status 178

iStrab – Product Description 178

MacCure Pipeline Products & Ongoing Clinical Trials Overview 179

Opthalmic Diagnostic Device – Macular Degeneration – Product Status 179

Opthalmic Diagnostic Device – Macular Degeneration – Product Description 179

Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 180

Portable Mydriatic Cameras – Product Status 180

Portable Mydriatic Cameras – Product Description 180

Retina Camera – Product Status 181

Retina Camera – Product Description 181

Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 182

Retinal Disease Evaluation Device – Product Status 182

Retinal Disease Evaluation Device – Product Description 182

Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 183

Intraocular Pressure Sensor – Product Status 183

Intraocular Pressure Sensor – Product Description 183

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 184

New Generation OCT – Product Status 184

New Generation OCT – Product Description 184

Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 185

Binocular Optical Coherence Tomography – Product Status 185

Binocular Optical Coherence Tomography – Product Description 185

Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 186

Corneal Trans-Epithelial Electrical Resistance Measurement Device – Product Status 186

Corneal Trans-Epithelial Electrical Resistance Measurement Device – Product Description 186

National Taiwan University Hospital Pipeline Products & Ongoing Clinical Trials Overview 187

Pupillometer – Product Status 187

Pupillometer – Product Description 187

National University Hospital Pipeline Products & Ongoing Clinical Trials Overview 188

SUPRA Perimetry Device – Product Status 188

SUPRA Perimetry Device – Product Description 188

National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 189

Victaz Device – Product Status 189

Victaz Device – Product Description 189

Neuro Kinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 190

I-Portal Retinopathy – Product Status 190

I-Portal Retinopathy – Product Description 190

NeuroFieldz Inc Pipeline Products & Ongoing Clinical Trials Overview 191

NeuroDotVR – Product Status 191

NeuroDotVR – Product Description 191

Neurolens Inc Pipeline Products & Ongoing Clinical Trials Overview 192

nMD2 – Product Status 192

nMD2 – Product Description 192

Neuroptics Inc. Pipeline Products & Ongoing Clinical Trials Overview 193

A-100 Device – Product Status 193

A-100 Device – Product Description 193

Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview 194

Retinal Spectral Imaging System – Product Status 194

Retinal Spectral Imaging System – Product Description 194

nGoggle Inc Pipeline Products & Ongoing Clinical Trials Overview 195

NGoggle – Product Status 195

NGoggle – Product Description 195

nGoggle Inc – Ongoing Clinical Trials Overview 196

NGoggle – Assessment of Visual Function with a Portable Brain-computer Interface 197

Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview 198

High – Speed Wavelength Swept Light – Based OCT Device – Product Status 198

High – Speed Wavelength Swept Light – Based OCT Device – Product Description 198

Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 199

Notal Home OCT System – Product Status 199

Notal Home OCT System – Product Description 199

Notal Vision Inc – Ongoing Clinical Trials Overview 200

Notal Home OCT System – Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision 201

Notal Home OCT System – Home OCT Fluid Visualization Agreement Study at Multiple Retinal Clinics with Placement of One Home OCT Device in the Home of Each NV-AMD Subject in the US for 5 Weeks 201

Notal Home OCT System – Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD 201

Notal Home OCT System – Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD 202

Nova Southeastern University Pipeline Products & Ongoing Clinical Trials Overview 203

Visual Field Evaluation Equipment – Product Status 203

Visual Field Evaluation Equipment – Product Description 203

NovaSight Pipeline Products & Ongoing Clinical Trials Overview 204

EyeSwift Pro – Product Status 204

EyeSwift Pro – Product Description 204

NovaSight – Ongoing Clinical Trials Overview 205

EyeSwift Pro – Prospective Clinical Trials to Assess Performance and Safety of EyeSwift Pro for Assessment of Ocular and Visual Functions 206

Objective Acuity Ltd Pipeline Products & Ongoing Clinical Trials Overview 207

Objective Acuity System – Product Status 207

Objective Acuity System – Product Description 207

Occuity Ltd Pipeline Products & Ongoing Clinical Trials Overview 208

AX1 Axiometer – Product Status 208

AX1 Axiometer – Product Description 208

Occuity PM1 Pachymeter – Product Status 209

Occuity PM1 Pachymeter – Product Description 209

OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 210

OcuMet Beacon – Product Status 210

OcuMet Beacon – Product Description 210

Ocutronics, LLC Pipeline Products & Ongoing Clinical Trials Overview 211

Ocutronics OC-100 Retinal Camera – Product Status 211

Ocutronics OC-100 Retinal Camera – Product Description 211

oDocs Eye Care Ltd Pipeline Products & Ongoing Clinical Trials Overview 212

visoClip – Product Status 212

visoClip – Product Description 212

visoScope – Product Status 213

visoScope – Product Description 213

Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 214

Interferometric Imaging System – Product Status 214

Interferometric Imaging System – Product Description 214

Oivi AS Pipeline Products & Ongoing Clinical Trials Overview 215

Oivi Fundus Camera – Product Status 215

Oivi Fundus Camera – Product Description 215

OKO Icare Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 216

DigiON Glaucoma Screening Device – Product Status 216

DigiON Glaucoma Screening Device – Product Description 216

Ophthalmic Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 217

IOPerfect – Product Status 217

IOPerfect – Product Description 217

IOPerfect Plus – Product Status 218

IOPerfect Plus – Product Description 218

Opticent Inc Pipeline Products & Ongoing Clinical Trials Overview 219

Aurora X3 – Product Status 219

Aurora X3 – Product Description 219

SS-vis-OCT – Product Status 220

SS-vis-OCT – Product Description 220

Optomed Oy Pipeline Products & Ongoing Clinical Trials Overview 221

Aurora IQ – Diabetic Retinopathy – Product Status 221

Aurora IQ – Diabetic Retinopathy – Product Description 222

OptoQuest Inc Pipeline Products & Ongoing Clinical Trials Overview 223

Vectralis – Product Status 223

Vectralis – Product Description 223

Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 224

200TX Replacement Device – Product Status 224

200TX Replacement Device – Product Description 225

CHARLOTTE – Product Status 225

CHARLOTTE – Product Description 225

Early Detection Device – Eye Disease – Product Status 226

Early Detection Device – Eye Disease – Product Description 226

Falcon I – Product Status 226

Falcon I – Product Description 227

Falcon II – Product Status 227

Falcon II – Product Description 227

INDIANAPOLIS – Product Status 228

INDIANAPOLIS – Product Description 228

Lotte – Product Status 228

Lotte – Product Description 229

Optos Plc – Ongoing Clinical Trials Overview 230

200TX Replacement Device – A Pilot Study to Assess the Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium 231

OptoVibronex LLC Pipeline Products & Ongoing Clinical Trials Overview 232

OptoScope 2.0 – Product Status 232

OptoScope 2.0 – Product Description 232

Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 233

Intelligent OCT Retinal Disease Screening System – Product Status 233

Intelligent OCT Retinal Disease Screening System – Product Description 233

Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 234

OCTA Test – Product Status 234

OCTA Test – Product Description 234

Oxford University Innovation Ltd Pipeline Products & Ongoing Clinical Trials Overview 235

Adaptive Optics Scanning Laser Ophthalmoscope – Product Status 235

Adaptive Optics Scanning Laser Ophthalmoscope – Product Description 235

PAIR Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 236

Cataract Diagnostic Device – Product Status 236

Cataract Diagnostic Device – Product Description 236

Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 237

Paramax – Product Status 237

Paramax – Product Description 237

PeriVision Pipeline Products & Ongoing Clinical Trials Overview 238

Virtual Eye Test – Product Status 238

Virtual Eye Test – Product Description 238

Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 239

AO-OCT System – Product Status 239

AO-OCT System – Product Description 239

Multimodal Adaptive Optics Retinal Imager (MAORI) – Product Status 240

Multimodal Adaptive Optics Retinal Imager (MAORI) – Product Description 240

PlenOptica Inc Pipeline Products & Ongoing Clinical Trials Overview 241

QuickSee Plus – Product Status 241

QuickSee Plus – Product Description 241

Predictek Inc Pipeline Products & Ongoing Clinical Trials Overview 242

IRis – Product Status 242

IRis – Product Description 242

Profundus AB Pipeline Products & Ongoing Clinical Trials Overview 243

Guide Star System – Product Status 243

Guide Star System – Product Description 243

REBIScan Inc Pipeline Products & Ongoing Clinical Trials Overview 244

Retinal Birefringence Imager – Product Status 244

Retinal Birefringence Imager – Product Description 244

Traq – Product Status 245

Traq – Product Description 245

REBIScan Inc – Ongoing Clinical Trials Overview 246

Traq – Head and Intraocular Trauma Tool for the Identification of Mild Traumatic Brain Injury 247

Regensight Srl Pipeline Products & Ongoing Clinical Trials Overview 248

TheraCXL – Keratoconus – Product Status 248

TheraCXL – Keratoconus – Product Description 248

Theravision – Low-Grade Myopia – Product Status 249

Theravision – Low-Grade Myopia – Product Description 249

Theravision – Presbyopia – Product Status 249

Theravision – Presbyopia – Product Description 250

Reichert Inc Pipeline Products & Ongoing Clinical Trials Overview 251

Tono-Vera Tonometer – Product Status 251

Tono-Vera Tonometer – Product Description 251

Reichert Inc – Ongoing Clinical Trials Overview 252

Tono-Vera Tonometer – Comparison of Intraocular Pressure Measurement with the Novel TonoVera Device with Other Commonly Used Devices 253

Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 254

Scheimpflug System – Product Status 254

Scheimpflug System – Product Description 254

RetinalGenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 255

RetinalGeniX Imaging System – Product Status 255

RetinalGeniX Imaging System – Product Description 255

Retinostics Pipeline Products & Ongoing Clinical Trials Overview 256

Ultra-high Resolution Scanning Laser Ophthalmoscope – Product Status 256

Ultra-high Resolution Scanning Laser Ophthalmoscope – Product Description 256

RetinScan Pipeline Products & Ongoing Clinical Trials Overview 257

Diabetics Retinopathy Digital Screening Device – Product Status 257

Diabetics Retinopathy Digital Screening Device – Product Description 257

RetInSight GmbH Pipeline Products & Ongoing Clinical Trials Overview 258

OCT-Based Screening Algorithm – Geographic Atrophy – Product Status 258

OCT-Based Screening Algorithm – Geographic Atrophy – Product Description 258

Retispec Inc Pipeline Products & Ongoing Clinical Trials Overview 259

Retispec – Product Status 259

Retispec – Product Description 259

Reyedar BV Pipeline Products & Ongoing Clinical Trials Overview 260

SONDA – Eye Diseases – Product Status 260

SONDA – Eye Diseases – Product Description 260

Rice University Pipeline Products & Ongoing Clinical Trials Overview 261

Diagnostic Device – Dry Eye – Product Status 261

Diagnostic Device – Dry Eye – Product Description 261

Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview 262

Pencil OCT – Product Status 262

Pencil OCT – Product Description 262

Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 263

Tonometer – Product Status 263

Tonomet

Figures

Ophthalmic Diagnostic Equipment – Pipeline Products by Stage of Development 31

Ophthalmic Diagnostic Equipment – Pipeline Products by Segment 32

Ophthalmic Diagnostic Equipment – Pipeline Products by Territory 33

Ophthalmic Diagnostic Equipment – Pipeline Products by Regulatory Path 35

Ophthalmic Diagnostic Equipment – Pipeline Products by Estimated Approval Date 36

Ophthalmic Diagnostic Equipment – Ongoing Clinical Trials 37

Frequently asked questions

Ophthalmic Diagnostic Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Ophthalmic Diagnostic Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Ophthalmic Diagnostic Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Ophthalmic Diagnostic Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.